The steep discount between trailing and forward multiples (P/E from 18.53 to 9.91) reflects the market's expectation of a sharp earnings rebound, consistent with the 31.8% revenue surge in 2026Q2. However, the PEG of 2.31 implies that the current growth rate is not sufficient to justify the valuation on a long-term basis, suggesting investors are skeptical about the durability of the recovery. Compared to peers like AVT (P/E 24.29) and SNX (P/E 25.50), ARW's forward multiples are lower, but this may be a value trap if the cyclical upswing reverses.

The 98% year-over-year growth in operating income in 2026Q2 demonstrates significant operating leverage, as SG&A grew only 14.5% against a 31.8% revenue increase. However, the gross margin has not recovered to the 12.3% level of 2024Q2, suggesting that pricing power remains constrained in a competitive distribution environment. Net margin of 2.7% is still thin, and the low effective tax rate that boosted net income may not be sustainable, warranting caution on earnings quality.

The 89% surge in total assets to $38.4B, driven by working capital, has diluted ROIC despite the earnings recovery. ROE of 3.9% and ROA of 0.7% are also low, reflecting the capital-intensive nature of distribution and the thin margins inherent in the model. The improvement from the 2025Q3 trough (ROIC 1.5%) is encouraging, but the absolute level suggests that the company is still in the early stages of a cyclical recovery, and returns may not reach historical norms if the cycle peaks soon.

The dramatic improvement in CCC is driven by a sharp increase in DPO to 266 days, which suggests ARW is stretching supplier payments to fund its working capital needs. However, DSO of 246 days is unusually high and may reflect extended payment terms granted to customers to drive sales, a common practice in distribution but one that increases credit risk. The asset turnover of 0.27 is low, consistent with the balance sheet expansion, and the efficiency gains may reverse if the cycle turns.

The reduction in debt is positive, but the low D/E understates leverage because payables and other current liabilities have ballooned, as noted in the balance sheet analysis. Interest coverage improved to 5.34 in 2026Q1 from 0.84 in 2025Q1, indicating that debt service is becoming more comfortable, but the cyclicality of earnings could quickly erode this coverage if demand softens. The reliance on supplier financing is a structural feature of the distribution model, but it exposes ARW to liquidity risk if suppliers tighten terms.

The improvement in cash flow is encouraging, but the declining current ratio and low cash balance suggest that ARW is deploying its cash into working capital to support growth. The quick ratio of 1.01 indicates that inventory is a significant component of current assets, and in a downturn, inventory may be hard to liquidate quickly. The company's ability to withstand a severe demand shock is questionable, given the thin liquidity buffer and the cyclicality of its cash flows.